Dr. Carol Kasper: Honoring the Legacy
Brian O Mahony, CEO of Irish Haemophilia Society,former President of WFH and EHC, shared a devastating news on X:
”I was immensely sad today to hear of the passing of Dr. Carol Kasper, a pioneering treater of haemophilia, a great researcher, a wonderful writer (her Hemophilia Bulletin in the 1990s and early 2000s was the best source of information). I had the great pleasure of working closely with Carol from 1994 to 2002 when she was Vice President Medical of The World Federation of Hemophilia and I was President. She was immensely knowledgable, a great teacher and very empatetic. She was great fun to travel with and had a great sense of humour. She added value to many lives.”
We are deeply saddened by the passing of Dr. Carol Kasper, a pioneering figure in hemophilia care and a beloved member of the global bleeding disorders community.
Dr. Kasper was not only a brilliant clinician and researcher but also a gifted communicator—her Hemophilia Bulletin in the 1990s and early 2000s remains one of the most insightful resources of its time.
Her legacy will live on!
Stay updated on the news in hematology field with Hemostasis Today.
-
Jul 11, 2025, 19:14ISTH 2025 for Cardiac Surgery: LEX-211 (FARES-II) Trial Shows Promising Results
-
Jul 11, 2025, 16:48GPAS 2025: Shaping the Future of Bleeding Disorder Care
-
Jul 10, 2025, 11:23HTRS Thanks CSL Behring for Its Ongoing Commitment to Research Support
-
Jul 9, 2025, 14:11Join Dr. Bethany Samuelson Bannow for a Virtual Event on Hemostasis and Cancer
-
Jul 9, 2025, 13:59Late-Breaking Insights from ISTH 2025: Rurioctocog Alfa Pegol in PUPs with Hemophilia A
-
Jul 11, 2025, 18:50ICAS Not a Factor: Post-EVT Intensive BP Control within 24 hrs Worsens Outcomes
-
Jul 11, 2025, 17:57Need for Recanalization Strategies Reinforced in P1 and P2: PCA Stroke Poor Outcomes
-
Jul 11, 2025, 15:40Wolfgang Miesbach: How to Better Understand and Explain Gene Therapy of Haemophilia?
-
Jul 11, 2025, 14:53Thrombosis with Thrombocytopenia, Post Vaccination Syndrome
-
Jul 10, 2025, 18:16Sex-Specific Models for ASAH Show No Added Benefit over SMA2SH2ERS risk predictions
-
Jul 7, 2025, 17:08Detecting Anti-Drug Antibodies to Emicizumab: A French Center’s Remarkable Experience
-
Jul 6, 2025, 21:00From Untouchable to Editable: How 21st-Century Gene Editing Breakthroughs Clash with Systemic Barriers
-
Mar 6, 2025, 17:15Olympus Announces Launch of Single-Use Hemostasis Clip
-
Jul 10, 2025, 18:25Dr. Carol Kasper: Honoring the Legacy
-
Jul 8, 2025, 08:26ASH and HVO Collaborate to Expand Hematology Training in LMICs
-
Jul 6, 2025, 15:02Patients as Experts: EHC Calls for Early Involvement in HTA Systems
-
Jul 6, 2025, 14:56Missed ISTH 2025? Congress Daily Has You Covered
-
Jul 6, 2025, 11:48Japan's Youth Engagement in Hemophilia Care: Where Even the Doctors Get It – HABIT Summit 2025